KR910007928A - 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물 - Google Patents

신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물 Download PDF

Info

Publication number
KR910007928A
KR910007928A KR1019900017460A KR900017460A KR910007928A KR 910007928 A KR910007928 A KR 910007928A KR 1019900017460 A KR1019900017460 A KR 1019900017460A KR 900017460 A KR900017460 A KR 900017460A KR 910007928 A KR910007928 A KR 910007928A
Authority
KR
South Korea
Prior art keywords
compound
radical
hydrogen atom
naphthyridine
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019900017460A
Other languages
English (en)
Korean (ko)
Inventor
안토인느 미쉘
바로 미쉘
데꼰끌로이스 장-후랑스와
지라드 필리페
삐까우트 구이
Original Assignee
라보 라뜨와 로 거 벨롱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8914203A external-priority patent/FR2653663A1/fr
Priority claimed from FR9008757A external-priority patent/FR2664595B1/fr
Application filed by 라보 라뜨와 로 거 벨롱 filed Critical 라보 라뜨와 로 거 벨롱
Publication of KR910007928A publication Critical patent/KR910007928A/ko
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019900017460A 1989-10-30 1990-10-30 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물 Ceased KR910007928A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8914203A FR2653663A1 (en) 1989-10-30 1989-10-30 Novel benzo[1,8]naphthyridine derivatives, their preparation and compositions containing them
FR8914203 1989-10-30
FR9008757A FR2664595B1 (fr) 1990-07-10 1990-07-10 Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent.
FR9008757 1990-07-10

Publications (1)

Publication Number Publication Date
KR910007928A true KR910007928A (ko) 1991-05-30

Family

ID=26227626

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900017460A Ceased KR910007928A (ko) 1989-10-30 1990-10-30 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물

Country Status (24)

Country Link
US (1) US5053509A (cg-RX-API-DMAC10.html)
EP (1) EP0431991B1 (cg-RX-API-DMAC10.html)
JP (1) JPH03151384A (cg-RX-API-DMAC10.html)
KR (1) KR910007928A (cg-RX-API-DMAC10.html)
AT (1) ATE100103T1 (cg-RX-API-DMAC10.html)
AU (1) AU629997B2 (cg-RX-API-DMAC10.html)
BG (1) BG60915B1 (cg-RX-API-DMAC10.html)
CA (1) CA2028730A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ280513B6 (cg-RX-API-DMAC10.html)
DE (1) DE69005994T2 (cg-RX-API-DMAC10.html)
DK (1) DK0431991T3 (cg-RX-API-DMAC10.html)
ES (1) ES2062455T3 (cg-RX-API-DMAC10.html)
FI (1) FI92068C (cg-RX-API-DMAC10.html)
HU (1) HU208138B (cg-RX-API-DMAC10.html)
IE (1) IE65099B1 (cg-RX-API-DMAC10.html)
IL (1) IL96159A (cg-RX-API-DMAC10.html)
NO (1) NO175433C (cg-RX-API-DMAC10.html)
NZ (1) NZ235890A (cg-RX-API-DMAC10.html)
PL (1) PL164270B1 (cg-RX-API-DMAC10.html)
PT (1) PT95743B (cg-RX-API-DMAC10.html)
RO (1) RO108347B1 (cg-RX-API-DMAC10.html)
RU (1) RU2047613C1 (cg-RX-API-DMAC10.html)
TW (1) TW214550B (cg-RX-API-DMAC10.html)
YU (1) YU47694B (cg-RX-API-DMAC10.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9309574B1 (en) 1984-08-22 2016-04-12 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Molecular cloning of HIV-1 from immortalized cell lines
FR2681865B1 (fr) * 1991-10-01 1993-11-19 Bel Laboratoire Roger Nouveaux derives de la benzonaphtyridine-1,8 leur preparation et les compositions qui les contiennent.
FR2703681B1 (fr) * 1993-04-08 1995-05-12 Bellon Labor Sa Roger Procede de preparation de fluoro-6-halogeno-2 quinoleine
US5883098A (en) * 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
RU2160092C2 (ru) * 1998-02-16 2000-12-10 Рязанский областной клинический кожно-венерологический диспансер Антимикробный препарат для лечения инфицированных ран
PT1140932E (pt) * 1998-12-21 2004-08-31 Aventis Pharma Sa Derivados de 1,8-benzonaftiridina
FR2787452B1 (fr) * 1998-12-21 2004-10-22 Aventis Pharma Sa Nouveaux derives de la benzonaphtyridine-1,8, leur preparation et les compositions pharmaceutiques qui les contiennent
DK1189903T3 (da) 1999-06-30 2003-09-22 Aventis Pharma Sa Nye benzo[f]naphthyridinderivater, deres fremstilling og præparater indeholdende disse derivater
FR2795729B1 (fr) * 1999-06-30 2001-08-10 Aventis Pharma Sa Nouveaux derives de la benzo[f]naphtyridine, leur preparation et les compositions les contenant
MY129850A (en) * 2002-04-29 2007-05-31 Merck Sharp & Dohme Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
AU2004287416C1 (en) * 2003-10-27 2010-09-09 Merck Sharp & Dohme Corp. CCR-2 antagonist salt
US8436176B2 (en) * 2004-12-30 2013-05-07 Medicis Pharmaceutical Corporation Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
KR101599524B1 (ko) * 2015-07-31 2016-03-03 (주)기억되는 사람들 유골함

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133885A (en) * 1977-07-18 1979-01-09 Merck & Co., Inc. Substituted naphthyridinones
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU623474B2 (en) * 1989-01-16 1992-05-14 Laboratoire Roger Bellon New benzo(1,8)naphthyridine derivatives, their preparation and compositions containing them

Also Published As

Publication number Publication date
TW214550B (cg-RX-API-DMAC10.html) 1993-10-11
FI92068C (fi) 1994-09-26
AU629997B2 (en) 1992-10-15
ATE100103T1 (de) 1994-01-15
YU205390A (sh) 1992-09-07
HU208138B (en) 1993-08-30
DE69005994D1 (de) 1994-02-24
NO904683D0 (no) 1990-10-29
DK0431991T3 (da) 1994-02-28
YU47694B (sh) 1996-01-08
RU2047613C1 (ru) 1995-11-10
NZ235890A (en) 1992-04-28
DE69005994T2 (de) 1994-05-11
RO108347B1 (ro) 1994-04-28
IE65099B1 (en) 1995-10-04
PL287563A1 (en) 1991-07-01
CA2028730A1 (fr) 1991-05-01
PT95743A (pt) 1991-09-13
CZ280513B6 (cs) 1996-02-14
HU906926D0 (en) 1991-05-28
NO904683L (no) 1991-05-02
AU6555190A (en) 1991-05-02
CZ529790A3 (en) 1995-11-15
FI92068B (fi) 1994-06-15
PT95743B (pt) 1997-09-30
BG60915B1 (bg) 1996-06-28
EP0431991A1 (fr) 1991-06-12
HUT55778A (en) 1991-06-28
IL96159A (en) 1994-12-29
FI905329A0 (fi) 1990-10-29
NO175433B (no) 1994-07-04
IL96159A0 (en) 1991-07-18
NO175433C (no) 1994-10-12
EP0431991B1 (fr) 1994-01-12
US5053509A (en) 1991-10-01
PL164270B1 (pl) 1994-07-29
IE903897A1 (en) 1991-05-08
ES2062455T3 (es) 1994-12-16
JPH03151384A (ja) 1991-06-27
BG93114A (bg) 1993-12-24

Similar Documents

Publication Publication Date Title
KR910007928A (ko) 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물
PT88410A (pt) Process for preparing thiazolidinedione derivatives
ATE118487T1 (de) Thiazolidinedionederivate.
DE3888756D1 (de) Carbamoylpyrrolidonderivate, ihre Verwendung und Herstellung.
KR860005794A (ko) 이미다졸 유도체의 제조방법
KR880700798A (ko) 신규한 인데노티아졸유도체 및 그 제조법
IL89156A (en) Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
PT76614A (de) Thiomethylpyridin-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NO855375L (no) Fremgangsmaate ved fremstilling av ureaderivater.
KR890012990A (ko) 삼치환된 아민 이들의 제법 및 이들을 함유하는 제약조성물
DK369289A (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
NZ535476A (en) 4-(diarylmethyl)-1-piperazinyl derivatives
ZA806584B (en) Guanidine compounds, process for preparing them and compositions containing them
SE8405338D0 (sv) (1,3) oxazino (4,3-a) isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
DE3772850D1 (de) Thiadiazinon-derivate.
KR930700501A (ko) 신규 설포닐 화합물

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19901030

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19950907

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19901030

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19980423

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19980707

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19980423

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I